|
OGFRL1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63535851527286E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.08909556320691E-11 |
| Normal-vs-Stage2 |
3.958200E-04 |
| Normal-vs-Stage3 |
4.84009999857093E-08 |
| Normal-vs-Stage4 |
1.93850000496099E-08 |
| Stage1-vs-Stage2 |
7.882400E-01 |
| Stage1-vs-Stage3 |
4.911400E-01 |
| Stage1-vs-Stage4 |
1.732620E-01 |
| Stage2-vs-Stage3 |
8.454000E-01 |
| Stage2-vs-Stage4 |
5.277000E-01 |
| Stage3-vs-Stage4 |
5.946200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.7715611723761E-16 |
| Normal-vs-AfricanAmerican |
1.567640E-01 |
| Normal-vs-Asian |
8.109800E-02 |
| Caucasian-vs-AfricanAmerican |
1.46359999997348E-06 |
| Caucasian-vs-Asian |
7.174600E-01 |
| AfricanAmerican-vs-Asian |
1.494430E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.89903648362133E-12 |
| Normal-vs-Female |
1.02310049321375E-10 |
| Male-vs-Female |
7.543000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.133700E-02 |
| Normal-vs-Age(41-60Yrs) |
3.70758979073571E-12 |
| Normal-vs-Age(61-80Yrs) |
1.45059519951474E-11 |
| Normal-vs-Age(81-100Yrs) |
2.075800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.343000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.773800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.594000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.449400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.669800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.200600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.371800E-04 |
| Normal-vs-Grade 2 |
1.38280054073903E-10 |
| Normal-vs-Grade 3 |
2.03059791203941E-12 |
| Normal-vs-Grade 4 |
1.70647999999662E-05 |
| Grade 1-vs-Grade 2 |
8.011000E-01 |
| Grade 1-vs-Grade 3 |
6.507800E-01 |
| Grade 1-vs-Grade 4 |
7.277000E-01 |
| Grade 2-vs-Grade 3 |
4.585200E-01 |
| Grade 2-vs-Grade 4 |
8.491000E-01 |
| Grade 3-vs-Grade 4 |
7.363600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.33066907387547E-16 |
| Normal-vs-ccB subtype |
3.40070000048875E-07 |
| ccA subtype-vs-ccB subtype |
8.188100E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.88258347483861E-14 |
| Normal-vs-N1 |
8.817500E-03 |
| N0-vs-N1 |
1.377620E-01 |
|
|
